Imagion Biosystems announced on ASX that it has received a total of $40,000 for the exercise of 800,000 Listed Options exercisable at 5 cents, expiring on 26 November 2021.
Please click to review the full announcement at ASX.
Chairman’s Address to Shareholders and Q&A Session at 2023 Annual General Meeting
May 25, 2023
Imagion Biosystems’ Chairman’s address to shareholders at the 2023 Annual General Meeting. PDF of the 2023 AGM Presentation Deck Watch the AGM 2023 Q&A Session